Searchable abstracts of presentations at key conferences in endocrinology

ea0032p356 | Diabetes | ECE2013

Risk factors for impaired glucose tolerance and diabetes mellitus after liver transplantation

Martinez Guillermo , Allo Gonzalo , Fernandez Ana , Aramendi Mercedes , Jimenez Carlos , Moreno Enrique , Hawkins Federico

Risk factors involved in new-onset diabetes mellitus after transplantation (NODAT) remain unclear. Clinical studies have demonstrated the association between low vitamin D levels with insulin resistance and diabetes. In animal models, osteocalcin deficiency leads to high glucose levels and insulin resistance.The aim of this study is to evaluate the prevalence of NODAT and other alterations of glucose metabolism after liver transplantation (LT) at our ins...

ea0032p420 | Diabetes | ECE2013

Relationship between metformin treatment and hyperlactacidemia diagnosed at the emergency room

Guelho Daniela , Paiva Isabel , Fonseca Isabel , Gouveia Sofia , Saraiva Joana , Moreno Carolina , Carvalheiro Manuela , Carrilho Francisco

Introduction: Renal function and glucose lowering therapy, particularly metformin, influence serum lactate concentration in patients with type 2 diabetes (T2D). However, seems to be an acute precipitating event that triggers hyperlactacidemia and metabolic acidosis. This study aims to assess prevalence of hyperlactacidemia in T2D patients who presented at emergency room (ER), calculate relative risk of hyperlactacidemia in diabetics under metformin, identify predictive factors...

ea0032p538 | Endocrine tumours and neoplasia | ECE2013

Incidental thyroid carcinomas in patients operated on for benign thyroid pathology, are there preoperative factors suggesting a higher risk?

Paja Miguel , Ugalde Aitziber , Barrios Borja , Oleaga Ameli , Calles Laura , Moreno Cristina , Ugarte Estibaliz , Oleaga Amelia

Introduction: The discovery of incidental thyroid carcinomas (ITC) in patients undergoing surgery for a benign disease range between 3 and 16% of cases. During years, patients with hyperthyroidism were considered protected by TSH suppression (TSH is well known factor that favors the development of thyroid cancer). Thyroid size might be a predictive factor due to the excess of thyroid tissue prone to mutations. The knowledge of determining factors foretelling the presence of un...

ea0029p128 | Adrenal medulla | ICEECE2012

Pheochromocytoma in neurofibromatosis type 1

Moreno C. , Bastos M. , Ruas L. , Vieira A. , Alves M. , Gouveia S. , Saraiva J. , Carvalheiro M.

IntroductionNeurofibromatosis type 1 (NF-1) is a relatively frequent syndrome, with an estimated incidence of 1/3000 per year. Patients with NF-1 are at an approximately fourfold higher risk of developing tumors than the general population, most frequently gastrointestinal stromal tumors, central nervous system tumors and endocrine tumors. Pheochromocytoma may occur in about 1% of these patients.Case report: We report a 56-year-old...

ea0029p402 | Clinical case reports - Thyroid/Others | ICEECE2012

Pendred’s syndrome: genetics and phenotypic variability

Alves M. , Bastos M. , Vieira A. , Gouveia S. , Saraiva J. , Moreno C. , Carvalheiro M.

Background: Pendred syndrome (PS) is an autosomal recessive disorder characterized by defective organification of iodine, goiter and deafness. It is caused by mutations in pendrin gene (SLC26A4), a transporter of chloride/iodide that mediates the efflux of iodine from thyroid follicular cells to the follicular lumen.Clinical case: Case-index: MJFS, female, refered to consultation at 35 years for enlarged neck. Personal history: congenital deafness, thyro...

ea0029p466 | Clinical case reports - Thyroid/Others | ICEECE2012

Ectopic Cushing’s syndrome and thymic hyperplasia

Vieira A. , Paiva I. , Alves M. , Gouveia S. , Saraiva J. , Moreno C. , Carrilho F. , Carvalheiro M.

Introduction: Thymic hyperplasia has been described after hypercortisolism resolution. The natural history remains poorly defined: emergence ≧1 month after hypercortisolism resolution, variable duration, usually spontaneous resolution/benign course.Case Report: ♂, 24, referred in 2000 for secondary hypothyroidism: TSH: 0.25 μUI/ml (0.25–5); FT4: 5.55 pmol/l (9–20). Clinical evaluation: insomnia, nocturnal sweating, facial eryt...

ea0029p1391 | Pituitary Clinical | ICEECE2012

Evaluation of clinical presentation, treatment approach and outcome of a cohort of patients with acromegaly: a single centre experience

Gouveia S. , Paiva I. , Ribeiro C. , Vieira A. , Alves M. , Saraiva J. , Moreno C. , Carvalheiro M.

Introduction: Acromegaly is a rare disease with a high morbidity and mortality rate.Our aim was to characterise the population with acromegaly that is currently under supervision at our Department.Materials and methods: We included 104 patients with acromegaly (mean age at the diagnosis 44.0±13.0; with 71.2% females).The referred population was analysed on what concerns disease’s duration, clinical ...

ea0029p1464 | Pituitary Clinical | ICEECE2012

Parasellar masses: experience in 47 patients

Saraiva J , Gomes L , Paiva I , Vieira A , Alves M , Gouveia S , Moreno C , Carvalheiro M

Introduction: The differential diagnosis of nonpituitary sellar masses is broad. Clinical presentation may be similar to that of pituitary adenomas. Sometimes certain findings are particular to some lesions and may help in their differentiation. Correct preoperative diagnosis is important to better guide therapeutic management. The aim of this work was to analyze patients with parasellar lesions (craniopharyngiomas excluded), attended in the Department of Endocrinology of our ...

ea0029p1806 | Thyroid cancer | ICEECE2012

Utility of repeated recombinant human TSH (rhTSH)-stimulated tiroglobulin (Tg) test in patients with differentiated thyroid carcinoma (DTC) without evidence of disease at their initial rh-TSH-stimulation test

Oleaga A. , Goni F. , Paja M. , Izuzquiza A. , Moreno C. , Arosa V. , Iglesias N. , Espiga J.

Current guidelines recommend measurement of rhTSH-stimulated Tg, with neck ultrasound 6–12 months after the initial therapy for DTC (Total thyroidectomy plus 100 mCiI131 ablation of the thyroid bed). Uncertainty persists regarding whether the subsequent follow up should be based on measurement of basal serum Tg or whether rhTSH-stimulated Tg should be performed and at what frequency. The aim of our study was to evaluate the utility of repeated rhTSH-stimulated Tg.<p c...

ea0026p467 | Thyroid cancer | ECE2011

Differences between incidental and preoperatively diagnosed papillary thyroid microcarcinomas. Review of the last decade

Paja M , Oleaga A , Ugalde A , Exposito A , Moreno C , Sanchez-Goitia M , Izuzquiza A J , Elorza J R

Increasing incidence of papillary thyroid microcarcinoma (PTMC) is due to accurate histological study of surgical specimens (incidental, INC) or to improved preoperative diagnostic techniques (preoperatively diagnosed, PD). We evaluate the differences between both groups of PTMC from 2000 to 2009.We reviewed data of patients diagnosed of PTMC (<10 mm) during the last decade with complete follow-up since surgery. Demographic data, tumour size, histolo...